6.70
price up icon2.13%   0.14
after-market After Hours: 6.70
loading
Precipio Inc stock is traded at $6.70, with a volume of 8,197. It is up +2.13% in the last 24 hours and up +2.13% over the past month. Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$6.56
Open:
$6.35
24h Volume:
8,197
Relative Volume:
0.79
Market Cap:
$9.80M
Revenue:
$15.81M
Net Income/Loss:
$-4.90M
P/E Ratio:
-0.7283
EPS:
-9.2
Net Cash Flow:
$-2.65M
1W Performance:
-0.74%
1M Performance:
+2.13%
6M Performance:
+0.00%
1Y Performance:
+19.43%
1-Day Range:
Value
$6.3499
$6.83
1-Week Range:
Value
$6.29
$6.8999
52-Week Range:
Value
$4.31
$8.99

Precipio Inc Stock (PRPO) Company Profile

Name
Name
Precipio Inc
Name
Phone
203 787 7888
Name
Address
12325 EMMET ST, OMAHA, CT
Name
Employee
57
Name
Twitter
@precipiodx
Name
Next Earnings Date
2024-08-15
Name
Latest SEC Filings
Name
PRPO's Discussions on Twitter

Precipio Inc Stock (PRPO) Latest News

pulisher
Sep 25, 2024

Long Term Trading Analysis for (PRPO) - Stock Traders Daily

Sep 25, 2024
pulisher
Sep 19, 2024

Precipio (NASDAQ:PRPO) Shares Pass Above Two Hundred Day Moving Average of $5.85 - Defense World

Sep 19, 2024
pulisher
Sep 14, 2024

When the Price of (PRPO) Talks, People Listen - Stock Traders Daily

Sep 14, 2024
pulisher
Sep 07, 2024

Precipio Incentivizes Staff with Strategic Stock Option Repricing - TipRanks

Sep 07, 2024
pulisher
Sep 06, 2024

Precipio Announces Employee Stock Option Plan Repricing - ForexTV.com

Sep 06, 2024
pulisher
Sep 06, 2024

Precipio Announces Stock Option Repricing for Employees - Investing.com

Sep 06, 2024
pulisher
Sep 06, 2024

Precipio Announces Stock Option Repricing for Employees - Investing.com India

Sep 06, 2024
pulisher
Sep 06, 2024

Precipio Announces Employee Stock Option Plan Repricing - StockTitan

Sep 06, 2024
pulisher
Sep 05, 2024

Zacks Initiates Coverage of Precipio With Outperform Recommendation - Yahoo Finance

Sep 05, 2024
pulisher
Aug 30, 2024

Objective long/short (PRPO) Report - Stock Traders Daily

Aug 30, 2024
pulisher
Aug 26, 2024

Head-To-Head Comparison: Prenetics Global (NASDAQ:PRE) vs. Precipio (NASDAQ:PRPO) - Defense World

Aug 26, 2024
pulisher
Aug 21, 2024

Precipio Inc (PRPO) Q2 2024 Earnings Call Transcript Highlights: Revenue Growth and Path to Profitability - GuruFocus.com

Aug 21, 2024
pulisher
Aug 21, 2024

Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost - Simply Wall St

Aug 21, 2024
pulisher
Aug 20, 2024

Precipio, Inc. (NASDAQ:PRPO) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 20, 2024
pulisher
Aug 20, 2024

Earnings call: Precipio Q2 2024 results show progress towards profitability By Investing.com - Investing.com Canada

Aug 20, 2024
pulisher
Aug 20, 2024

Precipio (NASDAQ:PRPO) Stock Price Passes Below 200-Day Moving Average of $5.85 - Defense World

Aug 20, 2024
pulisher
Aug 19, 2024

Precipio, Inc. (NASDAQ:PRPO) Q2 2024 Earnings Call Transcript - MSN

Aug 19, 2024
pulisher
Aug 16, 2024

Precipio Second Quarter 2024 Earnings: US$0.83 loss per share (vs US$1.88 loss in 2Q 2023) - Simply Wall St

Aug 16, 2024
pulisher
Aug 15, 2024

Precipio Announces Q2-2024 Shareholder Update Call - ForexTV.com

Aug 15, 2024
pulisher
Aug 15, 2024

Precipio Announces Q2-2024 Shareholder Update Call - TipRanks

Aug 15, 2024
pulisher
Aug 15, 2024

Precipio Announces Q2-2024 Shareholder Update Call - StockTitan

Aug 15, 2024
pulisher
Aug 13, 2024

PRPO Stock Earnings: Precipio Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024
pulisher
Aug 13, 2024

Hematologic Malignancies Testing Markets, 2023-2033: - GlobeNewswire

Aug 13, 2024
pulisher
Aug 10, 2024

Financial Survey: Precipio (NASDAQ:PRPO) vs. Prenetics Global (NASDAQ:PRE) - Defense World

Aug 10, 2024
pulisher
Aug 07, 2024

(PRPO) Trading Advice - Stock Traders Daily

Aug 07, 2024
pulisher
Jul 25, 2024

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven - StockTitan

Jul 25, 2024
pulisher
Jul 25, 2024

Precipio reports unaudited CBFO for Q2 was $0.3M - TipRanks

Jul 25, 2024
pulisher
Jul 17, 2024

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - ForexTV.com

Jul 17, 2024
pulisher
Jul 17, 2024

Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - StockTitan

Jul 17, 2024
pulisher
Jul 17, 2024

Precipio (NASDAQ:PRPO) Share Price Crosses Below 200-Day Moving Average of $6.00 - Defense World

Jul 17, 2024
pulisher
Jul 09, 2024

Precipio (NASDAQ:PRPO) Share Price Passes Below Two Hundred Day Moving Average of $6.08 - Defense World

Jul 09, 2024
pulisher
Jun 30, 2024

Precipio, Inc. (NASDAQ:PRPO) Short Interest Down 14.3% in June - Defense World

Jun 30, 2024
pulisher
Jun 29, 2024

Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average of $6.14 - Defense World

Jun 29, 2024
pulisher
Jun 21, 2024

Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average of $6.21 - Defense World

Jun 21, 2024
pulisher
Jun 16, 2024

PRPOPrecipio, Inc. Latest Stock News & Market Updates - StockTitan

Jun 16, 2024
pulisher
Jun 15, 2024

Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future - Yahoo Canada Sports

Jun 15, 2024
pulisher
Jun 14, 2024

(PRPO) Trading Signals - Stock Traders Daily

Jun 14, 2024
pulisher
Jun 13, 2024

Precipio says pathology revenue 'heading back towards' breakeven pointTipRanks.com - TipRanks

Jun 13, 2024
pulisher
Jun 13, 2024

Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders - GlobeNewswire Inc.

Jun 13, 2024
pulisher
Jun 12, 2024

Precipio faces $100,000 cost if shareholder meeting delayed By Investing.com - Investing.com UK

Jun 12, 2024
pulisher
Jun 12, 2024

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - GlobeNewswire Inc.

Jun 12, 2024
pulisher
Jun 12, 2024

Precipio on track for mid-year breakeven after setbacks By Investing.com - Investing.com

Jun 12, 2024
pulisher
Jun 12, 2024

Precipio Provides Status Update on Current Business Matters - StockTitan

Jun 12, 2024
pulisher
Jun 07, 2024

Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet - Simply Wall St

Jun 07, 2024
pulisher
Jun 07, 2024

It's Probably Less Likely That Precipio, Inc.'s (NASDAQ:PRPO) CEO Will See A Huge Pay Rise This Year - Yahoo Finance

Jun 07, 2024
pulisher
Jun 05, 2024

Precipio (NASDAQ:PRPO) Stock Passes Below 200-Day Moving Average of $6.32 - Defense World

Jun 05, 2024
pulisher
Jun 02, 2024

(PRPO) Investment Analysis and Advice - Stock Traders Daily

Jun 02, 2024
pulisher
Jun 01, 2024

Precipio (NASDAQ:PRPO) shareholders have endured a 44% loss from investing in the stock three years ago - Yahoo Eurosport UK

Jun 01, 2024
pulisher
May 28, 2024

Precipio (NASDAQ:PRPO) Shares Cross Below 200 Day Moving Average of $6.39 - Defense World

May 28, 2024
pulisher
May 27, 2024

Cancer Diagnostics Market to Grow at a 7% CAGR, Driven by Technological Advancements - PharmiWeb.com

May 27, 2024
pulisher
May 23, 2024

(PRPO) Investment Report - Stock Traders Daily

May 23, 2024

Precipio Inc Stock (PRPO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research LH
$223.48
price up icon 0.62%
$130.41
price up icon 0.22%
diagnostics_research WAT
$359.89
price up icon 0.72%
$287.31
price up icon 0.60%
diagnostics_research MTD
$1,499.70
price up icon 1.41%
$505.22
price down icon 1.28%
Cap:     |  Volume (24h):